Regulatory Intelligence Knowledge Hub

Insights for Medical Device Professionals

Practical PMS guidance for FDA and Health Canada first — with selected global reference content where useful. Written from the RA/QA perspective.

8 articles|4-level explanations
Showing:PMS ExplainedClear all8 articles
PMS Explained4 LevelsFebruary 18, 20261 min read

What Is PMCF and Do I Really Need It? 4-Level Guide (2026)

PMCF (Post-Market Clinical Follow-up) explained at 4 levels — from playground analogy to the MDD-to-MDR evidence crisis. Covers MDCG 2020-7/2020-8 templates, PMCF plan writing, method selection, and why 'not applicable' rarely works with Notified Bodies.

EU MDRPMCFPost-Market Clinical Follow-up
Read
PMS Explained4 LevelsFebruary 18, 20261 min read

How Do I Monitor Competitor Recalls for PMS? 4-Level Guide (2026)

Competitor recall monitoring explained at 4 levels — from playground analogy to strategic intelligence. Covers which databases to monitor, how to evaluate each signal, the regulatory requirement from EU MDR and FDA, and practical solutions for automated monitoring.

FDA recallsEU MDR Article 84competitor monitoringrecall monitoring
Read
PMS Explained4 LevelsFebruary 18, 20261 min read

What Will the Inspector Ask About My PMS System? 4-Level Guide (2026)

The exact questions FDA inspectors, EU Notified Body auditors, and MDSAP auditors ask about your PMS system — explained at 4 levels. Includes the 8 documents to have ready, the 'thread-pull' technique inspectors use, and how pre-inspection intelligence targets your weak spots.

FDA 483PMS inspectionNotified Body audit
Read
PMS Explained4 LevelsFebruary 18, 20261 min read

What Is a PSUR and How Do I Write One? 4-Level Guide (2026)

PSUR (Periodic Safety Update Report) explained at 4 levels — from a report card analogy to NB review strategy. Covers MDCG 2022-21 template, section-by-section guidance, common mistakes, and practical tips for RA/QA professionals writing their first PSUR.

EU MDRPSURPeriodic Safety Update Report
Read
PMS Explained4 LevelsFebruary 18, 20261 min read

When Must I Report an Adverse Event? Timelines for Every Country (2026)

Adverse event reporting explained at 4 levels — from simple analogy to multi-jurisdiction filing strategy. Includes the exact reporting timelines for FDA, EU MDR, Health Canada, Japan, Australia, and China, plus the reportability decision tree every RA/QA professional needs.

FDA MAUDEEU MDR Article 87Health Canadaadverse event reportingMDR reporting
Read
PMS Explained4 LevelsFebruary 18, 20261 min read

What Is Post-Market Surveillance? Explained at 4 Levels (2026)

Post-market surveillance explained at 4 levels — from a 5-year-old's analogy to top researcher analysis. Covers why PMS exists, what RA/QA professionals must do daily, the regulations across FDA/EU/HC, and where the field is heading with RWE and AI signal detection.

FDAEU MDRHealth Canadapost-market surveillancePMS explained
Read

See Your PMS Snapshot

Enter your device and see what needs review

Insights — PMS Guidance for FDA & Health Canada | TrueMedDevice